Critical Manufacturing

Critical Manufacturing is a provider of Manufacturing Execution Systems (MES) founded in 2009 and headquartered in Porto, Portugal. The company became a subsidiary of ASMPT (formerly ASM Pacific Technology) in 2018. With 550+ employees, Critical Manufacturing primarily serves the semiconductor, electronics, and medical device industries with its modular MES platform.

The company's flagship product features 30+ modular capabilities including Digital Twin technology (fabLIVE), Statistical Process Control (SPC), CAPA management, augmented reality monitoring, and IoT integration. Critical Manufacturing focuses on Industry 4.0 manufacturing solutions with advanced automation and real-time monitoring capabilities.

While the company serves medical device manufacturers including B. Braun, Elekta, and Ultradent, it is not pharma-focused and no pharmaceutical customer is named. The platform's primary market is semiconductor and electronics manufacturing with medical devices as a secondary vertical. The suitability of the platform for GxP-regulated pharmaceutical manufacturing is unknown.

Critical Manufacturing is not a pharma-focused company. The company primarily serves semiconductor and electronics manufacturing industries with medical devices as a secondary market. No pharmaceutical customer is named. Named medical device customers include B. Braun, Elekta, and Ultradent.

The platform features electronic signatures and audit trails (compliance features), but specific 21 CFR Part 11 compliance and GxP suitability for pharmaceutical manufacturing are unknown. The company's expertise and customer base are concentrated in semiconductor and electronics manufacturing, not pharmaceutical production.

Total customer count, pharma customer count, and percentage of customers that are pharma are undisclosed. The company does not appear to serve Big Pharma, biotech, or CDMO customers. Validation documentation availability for pharma use cases is unknown.

Critical Manufacturing raised $3.92M in funding prior to being acquired by ASMPT in 2018. As a subsidiary of ASMPT (formerly ASM Pacific Technology), the company benefits from the financial backing and resources of a publicly traded parent company. Annual revenue is not publicly disclosed. The company operates as a private entity within the ASMPT portfolio, focusing on MES solutions primarily for semiconductor and electronics manufacturing.

Critical Manufacturing offers a modular MES platform with 30+ capabilities designed for complex manufacturing environments. The product portfolio includes the core Critical Manufacturing MES with modules for production management, quality control, CAPA, Statistical Process Control (SPC), and supply chain integration.

Key differentiators include Digital Twin technology called fabLIVE for real-time manufacturing visualization, augmented reality monitoring capabilities, and comprehensive IoT integration for Industry 4.0 manufacturing. The platform is designed as a modular system allowing customers to implement specific capabilities based on their needs.

Cloud deployment options, mobile solutions, and AI capabilities are undisclosed. The platform is primarily targeted at semiconductor and electronics manufacturing with adaptations for medical device production. No pharma-specific edition or module is named.

Partnerships are undisclosed. As a subsidiary of ASMPT, the company likely benefits from ASMPT's ecosystem of technology partnerships, but no specific partnership with a cloud provider (AWS, Azure, Google Cloud), enterprise software vendor (SAP, Oracle, Salesforce), or pharmaceutical industry organisation is named.

Support and services are undisclosed. Global support availability, 24/7 support, regional coverage, professional services (implementation, validation, training, consulting), customer success programmes, user conferences, and community forums are undisclosed.

Critical Manufacturing is a subsidiary of ASMPT (since 2018), providing corporate backing and stability. The company has been operating since 2009 (15+ years) with 550+ employees. Industry recognition and analyst coverage (Gartner, Forrester) are undisclosed.

G2 reviews are unavailable. Security certifications (ISO 9001, ISO 27001, SOC 2) and quality certifications are undisclosed. Leadership team information is undisclosed.

Named medical device customers include B. Braun, Elekta, and Ultradent, all in regulated industries. Pharmaceutical-specific credentials and FDA inspection track record are unknown. Thought leadership activities (whitepapers, webinars, industry conference participation) are undisclosed.

Critical Manufacturing maintains a website at www.criticalmanufacturing.com. Website quality, freshness, and recent updates are undisclosed. Social media presence, press release frequency, content marketing activities (blog, whitepapers, videos), and demo/trial availability are unknown.

The company is a subsidiary of ASMPT, which provides corporate stability and resources. No pharmaceutical market presence is evidenced: no pharmaceutical customer is named, and the company's primary focus remains semiconductor and electronics manufacturing.